Financial News
Press Releases about Alnylam Pharmaceuticals
![](https://mms.businesswire.com/media/20231019367164/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20231009982660/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20231006913144/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Via Business Wire
![](https://www.marketbeat.com/logos/articles/med_20230924200315_argenxs-28-surge-promising-product-propel-investor.jpg)
![](https://mms.businesswire.com/media/20230913147234/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230913894129/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230907817269/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230906193116_3-stocks-to-buy-for-the-covid-resurgence.jpg)
![](https://mms.businesswire.com/media/20230825077123/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230803655131/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230802309582/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230723790893/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230720442183/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230719155322/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230716241827/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230629202575/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230605005662/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230520005007/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230504005271/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230503005757/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230503005131/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Alnylam Issues 2022 Corporate Responsibility Report
May 03, 2023
Via Business Wire
![](https://mms.businesswire.com/media/20230426005802/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230424135734_why-legend-biotech-stock-is-having-its-best-month.jpg)
![](https://mms.businesswire.com/media/20230420005146/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230308005250/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230301005134/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230223005143/en/1161817/5/Alnylam_Corporate_Logo.jpg)
![](https://mms.businesswire.com/media/20230221005335/en/1161817/5/Alnylam_Corporate_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.